NCT06824532

Brief Summary

The goal of this exploratory, mixed-method design study is to gather qualitative and quantitative data obtained through interviews and questionnaires with veterans who are currently enrolled at the VA for healthcare. The main question this study aims to answer is: How do veterans aged 65+ who are enrolled for care at the VA understand ketamine assisted psychotherapy for depression and for end-of-life distress? Using a story-completion approach, participants will be provided with a brief story starter involving a fictitious character and scenario and asking them to complete the story. Few contextual details will be offered about the character. In responding to ambiguous cues, participants are thought to project their conscious and subconscious perceptions about the phenomenon in question onto the story, a useful method for exploring stigmatized topics. The purpose of this exercise is to ascertain the participants attitudes and perceptions regarding ketamine assisted psychotherapy.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Nov 2024

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 8, 2024

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

February 6, 2025

Completed
7 days until next milestone

First Posted

Study publicly available on registry

February 13, 2025

Completed
16 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2025

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2025

Completed
Last Updated

February 13, 2025

Status Verified

February 1, 2025

Enrollment Period

4 months

First QC Date

February 6, 2025

Last Update Submit

February 11, 2025

Conditions

Outcome Measures

Primary Outcomes (3)

  • Patient Health Questionnaire 9

    Screening tool for depressive symptoms. Scores range from 0-27 with lower scores indicating better outcomes

    2 weeks

  • Ten Item Personality Inventory

    A 10-item measure of the Big Five dimensions is offered for situations when very short measures are needed, personality is not the primary topic of interest. It assesses the big-five traits-Emotional Stability, Extraversion, Openness, Agreeableness, and Conscientiousness-using two items for each scale. Scores range from 1-70.

    2 weeks

  • Death Anxiety Questionnaire

    The 15-item self report scale is a reliable and valid measure of individual differences in and perceptions of death anxiety. Scores range from 0-30 with higher scores indicate a higher level of anxiety.

    2 weeks

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersYes
Age GroupsOlder Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The demographic makeup of the sample mimics the demographic makeup of the population of veterans served by VA. As such, the racial distributions will likely be primarily Caucasian, the sample is likely to be predominantly male, ranging in age from 20-100, with an average of 58 years.

You may qualify if:

  • Veterans enrolled in VA care.
  • Age 65 or older.
  • Fluent in written and spoken English.

You may not qualify if:

  • Cognitively impaired to the extent that patient cannot comprehend the survey.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Stratton VA Medical Center

Albany, New York, 12208, United States

RECRUITING

MeSH Terms

Conditions

Depression

Condition Hierarchy (Ancestors)

Behavioral SymptomsBehavior

Study Officials

  • Caitlin Holley, Ph.D.

    Albany Research Institute, Inc.

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Caitlin Holley, Ph.D.

CONTACT

Stacey Farmer, Ph.D.

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Psychologist

Study Record Dates

First Submitted

February 6, 2025

First Posted

February 13, 2025

Study Start

November 8, 2024

Primary Completion

March 1, 2025

Study Completion

April 1, 2025

Last Updated

February 13, 2025

Record last verified: 2025-02

Locations